Back to search
Supratentorial Neoplasms, Malignant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Supratentorial Neoplasms, Malignant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Supratentorial Neoplasms, Malignant trials you may qualify forThe goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who…
Tumors of the pituitary gland comprise up to 20% of all brain tumors. The central location and the small size of the pituitary gland make the management of tumo…
Objective: This protocol is designed to allow evaluation of participants neurosurgical disorders that receive care within the Surgical Neurology Branch. The par…
This study is designed as a single institution trial. The study utilizes safe and clinically-validated tools for preoperative workup of patients with small pitu…
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass…
The purpose of this research is to evaluate the diagnostic role and clinical efficacy of investigational FET-PET/MRI in detecting MRI-occult primary or residual…
This phase II/III trial studies how well vocimagene amiretrorepvec (Toca 511) and extended release flucytosine (Toca FC) work when added to the usual treatment…
This study focuses on bringing artificial intelligence into the operating room to assist with pituitary tumour surgeries performed through the nose. These proce…
Lentiginosis refers to groups of diseases marked by the presence of pigmented spots on the skin. These conditions are most commonly associated with multiple tum…